Emerging Markets for Microfluidic Applications

Yole Developpement
August 1, 2009
206 Pages - SKU: YOLD2435097
License type:
Market and Technology Analysis of Microfluidic devices and technologies for Point of care diagnostics, Pharmaceutical and life science research, Analytical devices, Industrial & environmental testing, Drug delivery, and Clinical & veterinary diagnostics.

OBJECTIVES OF THE REPORT

The new Yole report presents microfluidics market data for 2006-2008 and market forecasts for 2009-2014 for life sciences and in-vitro-diagnostic applications, and provides detailed analysis of the market. A specific section is dedicated on the analysis of what happened over the last 3 years (including Alliances & mergers, new products, fund raising…), which are key elements to understand the actual and future microfluidic market.

MICROFLUIDIC APPLICATIONS

EMMA 09 report describes in detail the following applications:
  • Point of care diagnostics,
  • Pharmaceutical and life science research,
  • Analytical devices,
  • Industrial & environmental testing,
  • Drug delivery and clinical & veterinary diagnostics.
This analysis includes the market data, trends and drivers, key players and technologies. MICROFLUIDIC TECHNOLOGIES

The report provides an overview of the main fluid motion and manufacturing technologies. We describe, by application, the main material used (glass, polymer, silicon...), with their advantages and drawbacks.

MICROFLUIDIC SUPPLY CHAIN

The report describes the microfluidic supply chain, from R&D to commercialization and distribution. It shows for each type of material the main players and their role in the supply chain.

MICROFLUIDIC VALUE CHAIN

The analysis of the value chain provides an understanding of costs related to the different manufacturing steps (included packaging and quality control) in relation to the cost of the final product which includes reagent, commercialization and distribution costs.

MARKET

Microfluidic components are diverse and find many applications in the diagnostic and life Sciences fields. Microfluidics has entered the Life Sciences market as a key technology to provide solution to the market requirements in terms of:
  • Analysis automation
  • through:
  • high parallelisation
  • multiplex analysis
  • Reduced analysis cost by
  • lowering sample volume and reagents used
  • Faster analysis
  • Higher accuracy in fluid
  • dispensing.
In 2014, the market of microfluidic devices will exceed $3 billion. Drug discovery remains the first microfluidics market, and will continue to grow significantly as well. This is particularly true for the technologies enabling multiplexing. However, the largest growth is expected in the field of Point of Care diagnostics.

Today, some products are moving from research applications to the clinical diagnostics and point of care fields. However, this trend is limited due to the relative high manufacturing costs of many microfluidic devices and the fact that significant hurdles remain in the technology itself and its fusion into the healthcare system.

Please note: this is delivered as a PowerPoint presentation.